Subscription revenues of $1,184 million in Q4 2020, representing 32% year-over-year growth, 29% adjusted for constant currencySubscription billings of $1,828...
Results
Johnson & Johnson JNJ 2.71% stated it expects to report pivotal benefits of a massive medical trial of its Covid-19...
NEW YORK--(BUSINESS WIRE)--BlackRock Capital Investment Corporation (NASDAQ:BKCC) (“BCIC” or the “Company,” “we,” “us” or “our”) announced today certain preliminary estimates...